Revvity, Inc. - stock earnings
PKI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | 127.7 million USD | 741.2 million USD |
| 2022Q4 | 85.3 million USD | 711.8 million USD |
| 2022Q3 | 179.2 million USD | 599.4 million USD |
| 2022Q1 | 190.2 million USD | 1.4 billion USD |
| 2021Q4 | 127.7 million USD | 1.2 billion USD |
| 2021Q3 | 245.9 million USD | 1.2 billion USD |
| 2021Q2 | 379.3 million USD | 1.3 billion USD |
| 2021Q1 | 380.4 million USD | 1.4 billion USD |
| 2020Q4 | 176.7 million USD | 964.0 million USD |
PKI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 569.2 million USD | 3.3 billion USD |
| 2022 | 943.2 million USD | 5.1 billion USD |
| 2021 | 727.9 million USD | 3.8 billion USD |
| 2019 | 227.6 million USD | 2.9 billion USD |
| 2018 | 237.9 million USD | 2.8 billion USD |
| 2017 | 292.6 million USD | 2.3 billion USD |
PKI
Price: $115.24
Dividend Yield: 0.24%
Forward Dividend Yield: 0.24%
Payout Ratio: 4.82%
Dividend Per Share: 0.28 USD
Earnings Per Share: 5.81 USD
P/E Ratio: 41.45
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 504200
Ebitda: 121.8 millionMarket Capitalization: 15.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 41